Subscribe To
PETS / PetMed Express Announces Upcoming Conference Participation
PETS News
By Market Watch
October 31, 2023
PetMed's stock plunges to 19-year low as dividend yield to drop from 19% to zero
Investors in PetMed Express Inc.'s stock are suffering their worst day in 23 years, after the pet medication and supplies company reported disappointi more_horizontal
By Zacks Investment Research
October 30, 2023
PetMed (PETS) Reports Break-Even Earnings for Q2
PetMed (PETS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.18. This compares to earnings of $0.13 per sh more_horizontal
By Seeking Alpha
October 2, 2023
PetMed Express Still A 'Sell,' But There Are Hopes For A Turnaround
PetMed Express faces challenges from larger competitors and declining profitability. The company has a new management team and has made strategic inve more_horizontal
By GlobeNewsWire
September 7, 2023
PetMed Express Announces Upcoming Conference Participation
DELRAY BEACH, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health ExpertTM, today announced its part more_horizontal
By MarketBeat
August 2, 2023
PetMed Express: A Stock To Watch For A Potential Turnaround
Everyone wants to get in early, but there's such a thing as buying too early. If you think a stock has promise, that doesn't mean you should buy immed more_horizontal
By Seeking Alpha
July 31, 2023
PetMed Express, Inc. (PETS) Q1 2024 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:05 PM ET PetMed Express, Inc. (NASDAQ:PETS ) Q1 2024 Earnings Conference Call July 31, 2023, 16:30 PM ET Company P more_horizontal
By Zacks Investment Research
July 31, 2023
PetMed (PETS) Reports Break-Even Earnings for Q1
PetMed (PETS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.14 per sh more_horizontal
By Seeking Alpha
July 21, 2023
PetMed Express: I'd Take That Medicine (Rating Upgrade)
PetMed Express shares have returned a loss of 27.7% over the past 5 ½ months, however, the shares are reasonably cheap and the dividend yield is attr more_horizontal